What Vinay Prasad thinks about venture capital
Hematologist-oncologist and professor of epidemiology and biostatistics at UCSF. Director of the FDA's Center for Biologics Evaluation and Research from 2025 to 2026. Writes about cancer drugs, clinical-trial evidence and health policy; co-founder of Sensible Medicine.
Vinay Prasad did not write this page.
We collected these quotes from things they published elsewhere, and every quote links to where it was said. They have no account here and have not endorsed this site. Quotes are word for word; the short line under each one is our own restatement, not their wording. Their own site. Is this you? Claim it or ask us to remove it. Or tell us what is wrong here.
Filter venture capital · Newest first
Only Vinay Prasad on venture capital. See everyone on venture capital
1 dated position, 2026, in their own words. Our reading of what Vinay Prasad has said — not written or endorsed by them.
-
Our readingMany biotech companies have no factual basis and exist mainly to raise money to pay salaries.
Their wordsIf you look at biotech, there are thousands or tens of thousands of biotech companies that have no factual basis. Their products either don't work, they're not going to work, they don't make sense, they have toxicity that weighs benefit,
↗AI researchers take up smoking/ Elizabeth Holmes Film/ Moderna Stockyoutube.com 10th of 20 in this recording